KFSH scales preventive genomics with largest pre-implantation testing program in the Middle East

King Faisal Specialist Hospital and Research Centre is using embryo testing, genomic analysis and genetic counseling to help families avoid passing serious inherited conditions to the next generation. The Riyadh-based program has served thousands of families since 2001 and will be a focus at a healthcare summit in New York on Sept. 14.

Why it matters: - KFSH is shifting genetic care from diagnosis after disease appears to prevention before pregnancy. - The approach can help families reduce the risk of passing serious inherited conditions to children. - Earlier detection of inherited risk can reduce repeated testing, avoid complications and lower long-term care costs.

What happened: - King Faisal Specialist Hospital and Research Centre is running the Middle East's largest Pre-implantation Genetic Testing program by annual case volume. - The Riyadh-based program combines embryo testing, genomic analysis and genetic counseling for families at risk of inherited disease. - KFSH says the program has served thousands of families since its launch in 2001. - KFSH will discuss the preventive genomics model at the C3 US NYC Davos of Healthcare™ Summit 2026 on Sept. 14 in New York City.

The details: - The program uses whole-genome sequencing and next-generation sequencing to identify variants linked to serious inherited conditions. - Genetic counseling before and after testing helps families understand results and consider available options. - The program analyzes embryos for disease-causing mutations before implantation. - KFSH says the service gives families in Saudi Arabia and the wider region access to advanced testing before pregnancy. - The program connects premarital screening, prenatal diagnostics and precision medicine services across later stages of care. - KFSH says the program is performing nearly half the number of comparable procedures done across Europe combined. - KFSH previously estimated that preventing the lifelong medical burden of a serious inherited disorder could save about SAR 1 million a year in treatment and care costs.

Between the lines: - The program reflects a broader push to make genomic information clinically actionable instead of leaving test results as isolated data points. - The model also broadens the role of precision medicine from individual treatment to family planning and population-level prevention. - In a region where inherited disorders remain a major health challenge, access to preventive testing can change care pathways earlier.

What's next: - KFSH is using the New York summit appearance to highlight preventive genomics as a practical healthcare strategy. - The hospital is positioning prevention as a core application of precision medicine across the continuum of care. - KFSH's broader goal is to make genomic services ethically responsible and accessible for more families.

The bottom line: - KFSH is turning advanced genetic testing into a preventive tool for families, not just a diagnostic one. - The program's scale and regional reach make it a notable example of how genomics is moving into routine care planning.